Data suggests that dramatic weight loss, including via GLP-1 drugs, could save Americans big bucks in healthcare spending.
Zepbound, a drug with the main active ingredient tirzepatide, was found to be more helpful in helping people lose weight than ...
If you’ve spent any time on TikTok, you know how quickly health trends can take off—and the 90-30-50 diet plan is the latest ...
If you’ve thought about losing weight lately, you’re not alone. And you’re far from the first guy to look up the best weight ...
Postpartum weight loss can feel impossible at times, especially if the weight isn’t coming off as quickly as you expected.
Adults taking Zepbound lost 47% more weight on average than those taking Wegovy, according to clinical trial data from ...
However, Dr Kath McCullough, NHS England’s national speciality adviser for obesity, warned that weight loss jabs “are not a ...
Researchers have developed a new compound that combines GLP-1 and leptin, showing promising weight loss results in mice. This ...
Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has outperformed its main competitor, Wegovy, in a clinical ...
A new study is shedding light on which of two drugs currently approved by the U.S. Food and Drug Administration for weight ...
"Platforms often promote misinformation or oversimplified solutions," one expert told Newsweek about the findings.